Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ·Healthcare·Biotechnology
$14.07
+5.12%
Mkt Cap $1.11B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (13 analysts)
$35.00
Range $30.00 – $40.00
Implied Upside
+148.8%
Consensus $35.00 vs current $14.07
NASDAQ·Healthcare·Biotechnology
$14.07
+5.12%
Mkt Cap $1.11B
Buy
1
Hold
0
Sell
0
Price Target (13 analysts)
$35.00
Range $30.00 – $40.00
+148.8%
Consensus $35.00 vs current $14.07